Literature DB >> 6095071

Expression of the Rous sarcoma virus src gene in avian macrophages fails to elicit transformed cell phenotype.

L Lipsich, J S Brugge, D Boettiger.   

Abstract

Infection of avian macrophages with Rous sarcoma virus does not induce any changes in the morphology, growth behavior, or expression of macrophage-specific proteins. The absence of cellular transformation does not result from a block in the synthesis of viral proteins, since infectious viruses are released from a majority of cells in the culture. In this report, we examine the synthesis, processing, and functional activity of pp60src in Rous sarcoma virus-infected macrophages to determine whether the absence of transformation is due to an alteration in the functional expression of pp60src. Although the absolute level of pp60src was reduced compared with fibroblasts, the protein exhibited the same phosphorylation pattern and subcellular distribution and was able to phosphorylate immunoglobulin in the immune complex-protein kinase assay. These results imply that the failure of Rous sarcoma virus to transform macrophage may be due to a restriction in the cellular response to a functional src protein, perhaps due to the absence of cellular products which are essential for mediating pp60src-induced transformation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6095071      PMCID: PMC368926          DOI: 10.1128/mcb.4.7.1420-1424.1984

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  37 in total

1.  Identification of a transformation-specific antigen induced by an avian sarcoma virus.

Authors:  J S Brugge; R L Erikson
Journal:  Nature       Date:  1977-09-22       Impact factor: 49.962

2.  Transformation of chicken embryo retinal melanoblasts by a temperature-sensitive mutant of Rous sarcoma virus.

Authors:  D Boettiger; K Roby; J Brumbaugh; J Biehl; H Holtzer
Journal:  Cell       Date:  1977-08       Impact factor: 41.582

3.  Peptide analysis of the transformation-specific antigen from avian sarcoma virus-transformed cells.

Authors:  J Brugge; E Erikson; M S Collett; R I Erikson
Journal:  J Virol       Date:  1978-06       Impact factor: 5.103

4.  Protein kinase activity associated with the avian sarcoma virus src gene product.

Authors:  M S Collett; R L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

5.  Identification of a polypeptide encoded by the avian sarcoma virus src gene.

Authors:  A F Purchio; E Erikson; J S Brugge; R L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

6.  Evidence for the multiple oncogenic potential of cloned leukemia virus: in vitro and in vitro studies with avian erythroblastosis virus.

Authors:  T Graf; B Royer-Pokora; G E Schubert; H Beug
Journal:  Virology       Date:  1976-06       Impact factor: 3.616

7.  Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis.

Authors:  D W Cleveland; S G Fischer; M W Kirschner; U K Laemmli
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

8.  Transformation of chick embryo neuroretinal cells by Rous sarcoma virus in vitro: induction of cell proliferation.

Authors:  B Pessac; G Calothy
Journal:  Science       Date:  1974-08       Impact factor: 47.728

9.  Studies on single foci of hematopoietic cells transformed by avian myeloblastosis virus.

Authors:  C Moscovici; M Zanetti
Journal:  Virology       Date:  1970-09       Impact factor: 3.616

10.  Isolation and characterization of reticuloendotheliosis virus transformed bone marrow cells.

Authors:  R B Franklin; R L Maldonado; H R Bose
Journal:  Intervirology       Date:  1974       Impact factor: 1.763

View more
  1 in total

1.  Differentiation of myeloid cells is accompanied by increased levels of pp60c-src protein and kinase activity.

Authors:  C E Gee; J Griffin; L Sastre; L J Miller; T A Springer; H Piwnica-Worms; T M Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.